MD graduated from Paris VII University, Xavier Bichat Medical School, with 30 years of experience in Clinical development, Pharmacovigilance and Medical Affairs. It includes, within Boehringer Ingelheim, roles in France as Head of Medical Affairs and Pharmacovigilance and in Asia as Regional Head of Clinical Research. He joined Allecra Therapeutics in 2018 to lead the clinical development of cefepime-enmetazobactam combination.
Information about the presentation:
Phase 3 study results of the β-lactamase inhibitor enmetazobactam combined with cefepime in cUTI